Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
Public ClinicalTrials.gov record NCT02573233. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Exploratory, Double-blind, Placebo-controlled Study of the Effects of Dupilumab on Airway Inflammation of Adults With Persistent Asthma
Study identification
- NCT ID
- NCT02573233
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- Dupilumab SAR231893/REGN668 Drug
- Placebo Drug
- budesonide and formoterol Drug
- fluticasone propionate and salmeterol Drug
- mometasone furoate and formoterol Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2016
- Primary completion
- Jan 2, 2018
- Completion
- Jan 2, 2018
- Last update posted
- Apr 3, 2022
2016 – 2018
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840402 | Tucson | Arizona | 85724 | — |
| Investigational Site Number 840403 | Denver | Colorado | 80206 | — |
| Investigational Site Number 840401 | Boston | Massachusetts | 02115 | — |
| Investigational Site Number 840002 | St Louis | Missouri | 63110 | — |
| Investigational Site Number 840404 | Winston-Salem | North Carolina | 27157-1071 | — |
| Investigational Site Number 840028 | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02573233, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2022 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02573233 live on ClinicalTrials.gov.